And what's more- 131 puts us exactly halfway to our overall recruitment target!! #HalfWayThere #HappyDays 😀

#TrialUpdate! November sees Team Symbad hit our highest recruiting month since May, with 7 patients! SPFT - No longer in use & @QEGateshead remain in 1st and 2nd spot, after recruiting 2 patients each!

Does this sound like you? 🧠Want to help others learn about dementia ❤️Passionate about making your community more dementia-friendly 📢Looking to develop public-speaking skills Then the #DementiaFriends Champion volunteer role could be for you! ow.ly/IZOn30n169J

Music can be a powerful tool to help us reconnect with our loved ones who battle with Alzheimer's. Share your favorite song with us that you always sing with your loved one. 🎶 youtube.com/watch?v=-n_g-J…

"Alzheimer's is the scariest, most intimidating disease I've ever seen. With more support, we can drive more research and awareness to really make breakthroughs possible." - Zeena

Merry Christmas & a happy new year from all at the Norwich CTU - and for us at HEG it's been a pleasure to work with so many wonderful colleagues 🎅🤶🌲🎁🎄

As we approach Christmas, we’ll be showing our appreciation for staff across the NHS working to look after our friends, family and loved ones as well as each other. Look out for new videos of staff sharing their stories over the next week and join us in saying a huge #ThankYouNHS

I'd like to say thank you to all the #NIHR research teams that I monitor, for your hard work and dedication this past year. Please pass on my thanks to the many sites involved too, their contribution is essential and very much appreciated. Have a wonderful Christmas and New Year.

Team Symbad would like to thank everyone for their hard work and support of the trial this year! All the best for Christmas and 2019! #symbad

#TrialUpdate! Latest and first High Flyers of 2019 below! SPFT - No longer in use and @QEGateshead remain in the top spots! Current total now at 133 patients! :)

Great end to the week with a HTA-SYMBAD Trial Trial randomisation. Thank you to everyone SPFT - No longer in use, Centre for Dementia Studies and Research at Sussex Partnership NHS FT 💙 for supporting this important study.

Writing in Plain English can be really hard for researchers, so for a bit of #internationalclinicaltrialsday fun, we’ve challenged our staff to describe their trials in words of one syllable (inspired by @thecopperdoctor) – let’s see how creative they can be! #ICTD2020

Recruitment closed just prior to lock down – 246 participants recruited – fantastic work from all involved #SYMBAD

Brilliant support with delivery of trial medication and collecting follow-up data from participants during lock down #SYMBAD

Exciting news – SYMBAD primary outcome data all in, database locked, analysis under way. Results on the horizon #SYMBAD

Hi! Polly here, on behalf of Norwich Clinical Trials Unit. For Pint of Science UK #pint20 #pint20Norwich, we’d like to share some #PintSizedScience. Our trial managers, data programmers, statisticians, and healthcare experts work on high quality research to improve patient care. 1/5

To anyone having problems with the website link, please use sites.uea.ac.uk/NorwichCTU instead - thanks!

Led by Sube Banerjee, we show mirtazapine no better than placebo in treatment of agitation in AD. Concerns about antipsychotics have led to increased use of sedating antidepressants and even benzos here. Best to use low dose risperidone if drug indicated. sciencedirect.com/science/articl…